Edgewise Therapeutics, Inc.

This early-stage study tests the safety of a new drug called EDG-7500 in 24 healthy adults, both Japanese and Caucasian. Participants receive single or multiple doses, and researchers measure how the drug moves through the body. No treatment benefit is expected; the goal is to ga…